{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:53:45Z","timestamp":1778172825610,"version":"3.51.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1093\/hmg\/ddi004","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T20:13:08Z","timestamp":1099512788000},"page":"39-47","source":"Crossref","is-referenced-by-count":221,"title":["Orexin loss in Huntington's disease"],"prefix":"10.1093","volume":"14","author":[{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"first","affiliation":[]},{"given":"Joana","family":"Gil","sequence":"additional","affiliation":[]},{"given":"Marion L.C.","family":"Maat-Schieman","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Bj\u00f6rkqvist","sequence":"additional","affiliation":[]},{"given":"Heikki","family":"Tanila","sequence":"additional","affiliation":[]},{"given":"In\u00eas M.","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"given":"Ruben","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Natalija","family":"Popovic","sequence":"additional","affiliation":[]},{"given":"Nils","family":"Wierup","sequence":"additional","affiliation":[]},{"given":"Per","family":"Norl\u00e9n","sequence":"additional","affiliation":[]},{"given":"Jia-Yi","family":"Li","sequence":"additional","affiliation":[]},{"given":"Raymund A.C.","family":"Roos","sequence":"additional","affiliation":[]},{"given":"Frank","family":"Sundler","sequence":"additional","affiliation":[]},{"given":"Hindrik","family":"Mulder","sequence":"additional","affiliation":[]},{"given":"Patrik","family":"Brundin","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2004,11,3]]},"reference":[{"key":"key\n\t\t\t\t20171011145949_DDI004C1","doi-asserted-by":"crossref","unstructured":"Petersen, A. and Brundin, P. ( 2002 ) Huntington's disease: the mystery unfolds? Int. Rev. Neurobiol. , 53 , 315 \u2013339.","DOI":"10.1016\/S0074-7742(02)53012-9"},{"key":"key\n\t\t\t\t20171011145949_DDI004C2","doi-asserted-by":"crossref","unstructured":"The Huntington's Disease Collaborative Research Group. ( 1993 ) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell , 72 , 971 \u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"key\n\t\t\t\t20171011145949_DDI004C3","doi-asserted-by":"crossref","unstructured":"Reiner, A., Dragatsis, I., Zeitlin, S. and Goldowitz, D. ( 2003 ) Wild-type huntingtin plays a role in brain development and neuronal survival. Mol. Neurobiol. , 28 , 259 \u2013276.","DOI":"10.1385\/MN:28:3:259"},{"key":"key\n\t\t\t\t20171011145949_DDI004C4","doi-asserted-by":"crossref","unstructured":"Cattaneo, E., Rigamonti, D., Goffredo, D., Zuccato, C., Squitieri, F. and Sipione, S. ( 2001 ) Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci. , 24 , 182 \u2013188.","DOI":"10.1016\/S0166-2236(00)01721-5"},{"key":"key\n\t\t\t\t20171011145949_DDI004C5","doi-asserted-by":"crossref","unstructured":"DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. and Aronin, N. ( 1997 ) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science , 277 , 1990 \u20131993.","DOI":"10.1126\/science.277.5334.1990"},{"key":"key\n\t\t\t\t20171011145949_DDI004C6","doi-asserted-by":"crossref","unstructured":"Maat-Schieman, M.L., Dorsman, J.C., Smoor, M.A., Siesling, S., Van Duinen, S.G., Verschuuren, J.J., den Dunnen, J.T., Van Ommen, G.J. and Roos, R.A. ( 1999 ) Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J. Neuropathol. Exp. Neurol. , 58 , 129 \u2013137.","DOI":"10.1097\/00005072-199902000-00003"},{"key":"key\n\t\t\t\t20171011145949_DDI004C7","doi-asserted-by":"crossref","unstructured":"Kremer, H.P., Roos, R.A., Dingjan, G., Marani, E. and Bots, G.T. ( 1990 ) Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease. J. Neuropathol. Exp. Neurol. , 49 , 371 \u2013382.","DOI":"10.1097\/00005072-199007000-00002"},{"key":"key\n\t\t\t\t20171011145949_DDI004C8","doi-asserted-by":"crossref","unstructured":"Kremer, H.P., Roos, R.A., Dingjan, G.M., Bots, G.T., Bruyn, G.W. and Hofman, M.A. ( 1991 ) The hypothalamic lateral tuberal nucleus and the characteristics of neuronal loss in Huntington's disease. Neurosci. Lett. , 132 , 101 \u2013104.","DOI":"10.1016\/0304-3940(91)90443-W"},{"key":"key\n\t\t\t\t20171011145949_DDI004C9","doi-asserted-by":"crossref","unstructured":"Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et\u00a0al. ( 1996 ) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell , 87 , 493 \u2013506.","DOI":"10.1016\/S0092-8674(00)81369-0"},{"key":"key\n\t\t\t\t20171011145949_DDI004C10","doi-asserted-by":"crossref","unstructured":"Menalled, L.B. and Chesselet, M.F. ( 2002 ) Mouse models of Huntington's disease. Trends Pharmacol. Sci. , 23 , 32 \u201339.","DOI":"10.1016\/S0165-6147(00)01884-8"},{"key":"key\n\t\t\t\t20171011145949_DDI004C11","doi-asserted-by":"crossref","unstructured":"Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G.P. and Davies, S.W. ( 2000 ) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA , 97 , 8093 \u20138097.","DOI":"10.1073\/pnas.110078997"},{"key":"key\n\t\t\t\t20171011145949_DDI004C12","doi-asserted-by":"crossref","unstructured":"Iannicola, C., Moreno, S., Oliverio, S., Nardacci, R., Ciofi-Luzzatto, A. and Piacentini, M. ( 2000 ) Early alterations in gene expression and cell morphology in a mouse model of Huntington's disease. J. Neurochem. , 75 , 830 \u2013839.","DOI":"10.1046\/j.1471-4159.2000.0750830.x"},{"key":"key\n\t\t\t\t20171011145949_DDI004C13","doi-asserted-by":"crossref","unstructured":"Kremer, B., Tallaksen-Greene, S.J. and Albin, R.L. ( 1993 ) AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease. Neurology , 43 , 1593 \u20131595.","DOI":"10.1212\/WNL.43.8.1593"},{"key":"key\n\t\t\t\t20171011145949_DDI004C14","doi-asserted-by":"crossref","unstructured":"Beal, M.F. ( 2000 ) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. , 23 , 298 \u2013304.","DOI":"10.1016\/S0166-2236(00)01584-8"},{"key":"key\n\t\t\t\t20171011145949_DDI004C15","doi-asserted-by":"crossref","unstructured":"Katsuki, H. and Akaike, A. ( 2004 ) Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Neurobiol. Dis. , 15 , 61 \u201369.","DOI":"10.1016\/j.nbd.2003.09.003"},{"key":"key\n\t\t\t\t20171011145949_DDI004C16","doi-asserted-by":"crossref","unstructured":"de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, V.T., Bartlett, F.S., II et\u00a0al. ( 1998 ) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA , 95 , 322 \u2013327.","DOI":"10.1073\/pnas.95.1.322"},{"key":"key\n\t\t\t\t20171011145949_DDI004C17","doi-asserted-by":"crossref","unstructured":"Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Richardson, J.A., Kozlowski, G.P., Wilson, S. et\u00a0al. ( 1998 ) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell , 92 , 573 \u2013585.","DOI":"10.1016\/S0092-8674(00)80949-6"},{"key":"key\n\t\t\t\t20171011145949_DDI004C18","doi-asserted-by":"crossref","unstructured":"Siegel, J.M. ( 2004 ) Hypocretin (orexin): role in normal behavior and neuropathology. Annu. Rev. Psychol. , 55 , 125 \u2013148.","DOI":"10.1146\/annurev.psych.55.090902.141545"},{"key":"key\n\t\t\t\t20171011145949_DDI004C19","doi-asserted-by":"crossref","unstructured":"Chemelli, R.M., Willie, J.T., Sinton, C.M., Elmquist, J.K., Scammell, T., Lee, C., Richardson, J.A., Williams, S.C., Xiong, Y., Kisanuki, Y. et\u00a0al. ( 1999 ) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell , 98 , 437 \u2013451.","DOI":"10.1016\/S0092-8674(00)81973-X"},{"key":"key\n\t\t\t\t20171011145949_DDI004C20","doi-asserted-by":"crossref","unstructured":"Willie, J.T., Chemelli, R.M., Sinton, C.M., Tokita, S., Williams, S.C., Kisanuki, Y.Y., Marcus, J.N., Lee, C., Elmquist, J.K., Kohlmeier, K.A. et\u00a0al. ( 2003 ) Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron , 38 , 715 \u2013730.","DOI":"10.1016\/S0896-6273(03)00330-1"},{"key":"key\n\t\t\t\t20171011145949_DDI004C21","doi-asserted-by":"crossref","unstructured":"Hara, J., Beuckmann, C.T., Nambu, T., Willie, J.T., Chemelli, R.M., Sinton, C.M., Sugiyama, F., Yagami, K., Goto, K., Yanagisawa, M. et\u00a0al. ( 2001 ) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron , 30 , 345 \u2013354.","DOI":"10.1016\/S0896-6273(01)00293-8"},{"key":"key\n\t\t\t\t20171011145949_DDI004C22","doi-asserted-by":"crossref","unstructured":"Siegel, J.M. ( 1999 ) Narcolepsy: a key role for hypocretins (orexins). Cell , 98 , 409 \u2013412.","DOI":"10.1016\/S0092-8674(00)81969-8"},{"key":"key\n\t\t\t\t20171011145949_DDI004C23","doi-asserted-by":"crossref","unstructured":"Ripley, B., Overeem, S., Fujiki, N., Nevsimalova, S., Uchino, M., Yesavage, J., Di Monte, D., Dohi, K., Melberg, A., Lammers, G.J. et\u00a0al. ( 2001 ) CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions. Neurology , 57 , 2253 \u20132258.","DOI":"10.1212\/WNL.57.12.2253"},{"key":"key\n\t\t\t\t20171011145949_DDI004C24","doi-asserted-by":"crossref","unstructured":"Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R. et\u00a0al. ( 2000 ) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. , 6 , 991 \u2013997.","DOI":"10.1038\/79690"},{"key":"key\n\t\t\t\t20171011145949_DDI004C25","doi-asserted-by":"crossref","unstructured":"Mikkelsen, J.D., Hauser, F., deLecea, L., Sutcliffe, J.G., Kilduff, T.S., Calgari, C., Pevet, P. and Simonneaux, V. ( 2001 ) Hypocretin (orexin) in the rat pineal gland: a central transmitter with effects on noradrenaline-induced release of melatonin. Eur. J. Neurosci. , 14 , 419 \u2013425.","DOI":"10.1046\/j.0953-816x.2001.01655.x"},{"key":"key\n\t\t\t\t20171011145949_DDI004C26","doi-asserted-by":"crossref","unstructured":"Helmlinger, D., Yvert, G., Picaud, S., Merienne, K., Sahel, J., Mandel, J.L. and Devys, D. ( 2002 ) Progressive retinal degeneration and dysfunction in R6 Huntington's disease mice. Hum. Mol. Genet. , 11 , 3351 \u20133359.","DOI":"10.1093\/hmg\/11.26.3351"},{"key":"key\n\t\t\t\t20171011145949_DDI004C27","doi-asserted-by":"crossref","unstructured":"Beal, M.F. and Ferrante, R.J. ( 2004 ) Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat. Rev. Neurosci. , 5 , 373 \u2013384.","DOI":"10.1038\/nrn1386"},{"key":"key\n\t\t\t\t20171011145949_DDI004C28","doi-asserted-by":"crossref","unstructured":"Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, E.P., Jr ( 1985 ) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. , 44 , 559 \u2013577.","DOI":"10.1097\/00005072-198511000-00003"},{"key":"key\n\t\t\t\t20171011145949_DDI004C29","doi-asserted-by":"crossref","unstructured":"Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P.J., Nishino, S. and Mignot, E. ( 1999 ) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell , 98 , 365 \u2013376.","DOI":"10.1016\/S0092-8674(00)81965-0"},{"key":"key\n\t\t\t\t20171011145949_DDI004C30","doi-asserted-by":"crossref","unstructured":"Beuckmann, C.T., Sinton, C.M., Williams, S.C., Richardson, J.A., Hammer, R.E., Sakurai, T. and Yanagisawa, M. ( 2004 ) Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy\u2013cataplexy in the rat. J. Neurosci. , 24 , 4469 \u20134477.","DOI":"10.1523\/JNEUROSCI.5560-03.2004"},{"key":"key\n\t\t\t\t20171011145949_DDI004C31","doi-asserted-by":"crossref","unstructured":"Li, S.H., Yu, Z.X., Li, C.L., Nguyen, H.P., Zhou, Y.X., Deng, C. and Li, X.J. ( 2003 ) Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J. Neurosci. , 23 , 6956 \u20136964.","DOI":"10.1523\/JNEUROSCI.23-17-06956.2003"},{"key":"key\n\t\t\t\t20171011145949_DDI004C32","doi-asserted-by":"crossref","unstructured":"Cepeda, C., Hurst, R.S., Calvert, C.R., Hernandez-Echeagaray, E., Nguyen, O.K., Jocoy, E., Christian, L.J., Ariano, M.A. and Levine, M.S. ( 2003 ) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J. Neurosci. , 23 , 961 \u2013969.","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003"},{"key":"key\n\t\t\t\t20171011145949_DDI004C33","doi-asserted-by":"crossref","unstructured":"Lievens, J.C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L. and Bates, G.P. ( 2001 ) Impaired glutamate uptake in the R6 huntington's disease transgenic mice. Neurobiol. Dis. , 8 , 807 \u2013821.","DOI":"10.1006\/nbdi.2001.0430"},{"key":"key\n\t\t\t\t20171011145949_DDI004C34","doi-asserted-by":"crossref","unstructured":"Nicniocaill, B., Haraldsson, B., Hansson, O., O'Connor, W.T. and Brundin, P. ( 2001 ) Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6\/1 Huntington transgenic mice. Eur. J. Neurosci. , 13 , 206 \u20132010.","DOI":"10.1046\/j.0953-816X.2000.01379.x"},{"key":"key\n\t\t\t\t20171011145949_DDI004C35","doi-asserted-by":"crossref","unstructured":"Hansson, O., Guatteo, E., Mercuri, N.B., Bernardi, G., Li, X.J., Castilho, R.F. and Brundin, P. ( 2001 ) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur. J. Neurosci. , 14 , 1492 \u20131504.","DOI":"10.1046\/j.0953-816x.2001.01767.x"},{"key":"key\n\t\t\t\t20171011145949_DDI004C36","doi-asserted-by":"crossref","unstructured":"Li, H., Wyman, T., Yu, Z.X., Li, S.H. and Li, X.J. ( 2003 ) Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum. Mol. Genet. , 12 , 2021 \u20132030.","DOI":"10.1093\/hmg\/ddg218"},{"key":"key\n\t\t\t\t20171011145949_DDI004C37","doi-asserted-by":"crossref","unstructured":"Behrens, P.F., Franz, P., Woodman, B., Lindenberg, K.S. and Landwehrmeyer, G.B. ( 2002 ) Impaired glutamate transport and glutamate\u2013glutamine cycling: downstream effects of the Huntington mutation. Brain , 125 , 1908 \u20131922.","DOI":"10.1093\/brain\/awf180"},{"key":"key\n\t\t\t\t20171011145949_DDI004C38","doi-asserted-by":"crossref","unstructured":"Hansson, O., Petersen, A., Leist, M., Nicotera, P., Castilho, R.F. and Brundin, P. ( 1999 ) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl Acad. Sci. USA , 96 , 8727 \u20138732.","DOI":"10.1073\/pnas.96.15.8727"},{"key":"key\n\t\t\t\t20171011145949_DDI004C39","doi-asserted-by":"crossref","unstructured":"Morton, A.J., Lagan, M.A., Skepper, J.N. and Dunnett, S.B. ( 2000 ) Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation. J. Neurocytol. , 29 , 679 \u2013702.","DOI":"10.1023\/A:1010887421592"},{"key":"key\n\t\t\t\t20171011145949_DDI004C40","doi-asserted-by":"crossref","unstructured":"Petit, D., Gagnon, J.F., Fantini, M.L., Ferini-Strambi, L. and Montplaisir, J. ( 2004 ) Sleep and quantitative EEG in neurodegenerative disorders. J. Psychosom. Res. , 56 , 487 \u2013496.","DOI":"10.1016\/j.jpsychores.2004.02.001"},{"key":"key\n\t\t\t\t20171011145949_DDI004C41","doi-asserted-by":"crossref","unstructured":"Mignot, E., Lammers, G.J., Ripley, B., Okun, M., Nevsimalova, S., Overeem, S., Vankova, J., Black, J., Harsh, J., Bassetti, C. et\u00a0al. ( 2002 ) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. , 59 , 1553 \u20131562.","DOI":"10.1001\/archneur.59.10.1553"},{"key":"key\n\t\t\t\t20171011145949_DDI004C42","doi-asserted-by":"crossref","unstructured":"Yu, Z.X., Li, S.H., Nguyen, H.P. and Li, X.J. ( 2002 ) Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum. Mol. Genet. , 11 , 905 \u2013914.","DOI":"10.1093\/hmg\/11.8.905"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/14\/1\/39\/17241999\/ddi004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T04:14:54Z","timestamp":1544933694000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/14\/1\/39\/2355781\/Orexin-loss-in-Huntingtons-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,11,3]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddi004","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1,1]]},"published":{"date-parts":[[2004,11,3]]}}}